Brenntag Specialties signs distribution agreement with Greenyn Biotechnology to serve pharma customers in Asia-Pacific

The distribution agreement covers plant extract products for the complementary medicine segment

Brenntag has signed a distribution agreement with Greenyn Biotechnology which encompasses a range of solutions such as Insumate bitter melon peptides, Antromax Antrodia Cinnamomea and Zymologist fermented fruit and vegetable extract.

Greenyn Biotechnology is an international company headquartered in Taichung, Taiwan specialising in dietary supplements. Over the last decade, Greenyn Biotechnology has obtained multiple international food quality system certifications such as FSSC 22000, ISO 22000, HACCP, TQF, HALAL, ISO/IEC 17025, and GMP.

“We are excited to announce our strategic collaboration with Brenntag to serve the surge in the consumption of complementary medicine as consumers in the Asia Pacific prioritise holistic approaches to health and well-being. By leveraging the combined prowess of both companies’ strengths in product development and marketing and with Brenntag’s extensive distribution network, we can cater to evolving consumer preferences with innovative formulations, personalized supplements, and tailored health solutions,” said Chia-Fen Wu, chairman of Greenyn Biotechnology.

Romain Girard, regional president of Pharma Asia-Pacific at Brenntag Specialties, said: “Brenntag prioritises the prevention of chronic diseases, and our partnership with Greenyn Biotechnology signifies a concerted effort towards enhancing access to high-quality and scientifically proven complementary medicines for the Asian population. Backed by the robust endorsement of the US FDA, these medicines hold immense potential in promoting holistic well-being. We eagerly anticipate this collaboration, rooted in principles of excellence, innovation, and a shared commitment to advancing healthcare.”